St. Luke's Health System -
First Four Patients in Houston Enrolled in Study to Test Dissolving Device in Treatment of Heart Disease
St. Luke's Medical Center (SLMC) - home of the Texas Heart® Institute (THI) - recently enrolled four patients with coronary artery disease (CAD), into a study to evaluate the potential benefits of a dissolving device, similar to a metallic stent.
St. Luke’s Medical Center Receives Get With The Guidelines® – Stroke Gold Plus Achievement Award
SLMC has been recognized with this award longer than any other hospital in Houston
St. Luke’s Cancer Center Conducting Clinical Research Study for Advanced Pancreatic Cancer
St. Luke’s Cancer Center at St. Luke’s Medical Center (SLMC) has begun a clinical research study for patients with advanced pancreatic cancer to determine if Kangalaite injections (KLTi) improve the effectiveness of gemcitabine, a chemotherapy drug approved by the Food & Drug Administration (FDA).
St. Luke’s and The University of Texas School of Public Health Unite to Perform First Successful Adult Fecal Microbial Transplant
FMT program is the first in Houston helping adults with recurrent Clostridium difficile associated diarrhea (CDAD or “C diff”) and other forms of chronic diarrhea
David J. Fine Accepts Position as President of CHI Institute for Research and Innovation
David J. Fine, president and chief executive officer of St. Luke's Health System (SLHS), announced today that he has accepted a position as president of a national research institute operated by Catholic Health Initiatives (CHI), parent of St. Luke's.
St. Luke's Medical Center First in Houston to Investigate Potential New Treatment for Gastric and Esophageal Cancers
St. Luke’s Medical Center in the Texas Medical Center is the first site in Houston selected for a Phase 2 clinical study of the bispecific antibody, MM-111, for the treatment of advanced gastric, esophageal and gastroesophageal junction (GEJ) cancers.
St. Luke’s Medical Center First in Texas to Implant AIGISRx® R Fully Bioresorbable Antibacterial Envelope
Device Significantly Reduces Infection Chances Following Surgery
New Formula Minimizes Recovery Time After Rhinoplasty Surgery
Using a new formula that combines a herbal remedy with a Swiss Therapy Chilled Gel Mask, Etai Funk, MD, FACS ?a board-certified facial plastic surgeon and ear, nose and throat surgeon at St. Luke’s Medical Center (SLMC)?has experienced success in reducing patient recovery time from rhinoplasty surgery to just one week.
Catholic Health Initiatives, Texas Heart Institute Sign Letter of Intent to Finalize Partnership Agreement Worth $220 Million
Catholic Health Initiatives (CHI) and the Texas Heart® Institute (THI) announced they have signed a letter of intent for exclusive negotiations toward a new partnership, funded by $220 million over the next decade for research and education in cardiovascular diseases.
St. Luke’s Medical Center Heart Patient Pete Huttlinger Releases Acoustic Guitar Album
15-track McGuire’s Landing now available on iTunes, Amazon.com, CD Baby and other outlets
St. Luke's Episcopal Health System news articles dating back to June of 2008